Bavarian Nordic — November 2020
-
-
Til alle jer som endnu ikke er Plus-supporter: https://www.proinvestor.com/donation
-
God morgen.
-
Velkommen til den nye AMBU chat https://www.proinvestor.com/index.php?p=group&groupid=126
-
God morgen.
-
-
"Two Phase 3 trials are ongoing with results expected in 2020. The first Phase 3 trial is with 32 CHI children aged 3 months to 12
years, and the second Phase 3 trial is with 12 CHI children from 7 days up to one year of age.
" -
Det første af de to phase III studier i CHI er i hvert fald markeret som completed på clinicaltrials.gov, så der kunne muligvis komme noget data der. Ligeledes er de allerede gået i gang med at rekruttere til deres phase Ib studie af ZP7570 (GLP-1/GLP-2 dual agonist), så også mulighed for data fra deres phase Ia. Og enig med exitnu, spændende med salget
-
Bavarian opjusterer resultatet for de første 9 måneder.
-
Bavarian løfter forventninger og vækster på omsætning og bundlinjehttps://www.proinvestor.com/investornyt/669498/bavarian-lofter-forventninger-og-vaekster-pa-omsaetning-og-bundlinje
-
Om dansk pharma efter 10 min. https://www.proinvestor.com/index.php?p=debat_1&postid=88419
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind